论文部分内容阅读
A dopamine agonist is the preferred therapy for all prolactinomas and the goals of treatment are to normalize prolactin, restore gonadal function and fertility, reduce tumor size and reverse pituitary dysfunction. Despite the efficacy and widespread use of dopamine agonists, the optimal duration of therapy, outcome of drug withdrawal and the safety of long term therapy have not been established.